You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abscopal Effect

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy Trial in Chongqing (Super-hyperfractionation Pulse Radiotherapy)

Recruiting
  • Lung Cancer
  • +2 more
  • Super-hyperfractionation Pulse Radiotherapy
  • Chongqing, Chongqing, China
  • +1 more
Feb 22, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Hepatocellular Carcinoma, Gastric Cancer Trial in Orange (Nivolumab Injectable Product, Trans-arterial tirapazamine

Recruiting
  • Hepatocellular Carcinoma
  • Gastric Cancer
  • Nivolumab Injectable Product
  • Trans-arterial tirapazamine embolization
  • Orange, California
    University of California, Irvine
Apr 13, 2022

Metastatic Melanoma Trial in Baltimore (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Stereotactic Body Radiation Therapy

Withdrawn
  • Metastatic Melanoma
  • Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
  • Stereotactic Body Radiation Therapy (SBRT)
  • Baltimore, Maryland
  • +1 more
Apr 7, 2021

NSCLC Metastatic, Cryotherapy Effect Trial in Montreal (Cryo-activation, Pembrolizumab)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Cryotherapy Effect
  • Montreal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Jun 22, 2022

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022

Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

Recruiting
  • Oncology
  • moderate Whole Body Hyperthermia (mWBH)
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
Apr 6, 2023

Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell Trial in San Diego, Saint Augustine (LTX-315 Part 1, LTX-315

Recruiting
  • Basal Cell Carcinoma
  • +3 more
  • LTX-315 Part 1
  • +2 more
  • San Diego, California
  • +1 more
Mar 21, 2022

Colorectal Cancer Metastatic Trial in Napoli (Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Colorectal Cancer Metastatic
  • Stereotactic Body Radiation Therapy (SBRT)
  • Napoli, Italy
    Istituto Nazionale Tumori - Fondazione G. Pascale
Apr 6, 2022

Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

Recruiting
  • Sarcoma
  • +2 more
  • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023

Hepatocellular Carcinoma Trial in Toronto (Pembrolizumab, Stereotactic Body Radiotherapy (SBRT))

Recruiting
  • Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

Metastasis From Malignant Melanoma of Skin (Diagnosis) Trial in Lausanne (FLASH therapy)

Recruiting
  • Metastasis From Malignant Melanoma of Skin (Diagnosis)
  • FLASH therapy
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Aug 24, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

Not yet recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • CodaLytic
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma Trial in Darmstadt, MIlan, Pavia (Carbon Ion

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Carbon Ion Therapy
  • Immunotherapy (Pembrolizumab)
  • Darmstadt, Germany
  • +3 more
Feb 11, 2022

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

Advanced Biliary Tract Cancer Trial in Beijing (OXA, 5-FU and bevacizumab plus Toripalimab)

Recruiting
  • Advanced Biliary Tract Cancer
  • OXA, 5-FU and bevacizumab plus Toripalimab
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Nov 26, 2021

Soft-tissue Sarcoma Trial in London (Compound 451238)

Active, not recruiting
  • Soft-tissue Sarcoma
  • Compound 451238
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Dec 14, 2021

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022

Uterine Cervical Tumors Trial in Wuhan (BS-006)

Not yet recruiting
  • Uterine Cervical Neoplasms
  • BS-006
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 6, 2022

Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

Recruiting
  • Metastatic Solid Tumor
  • +3 more
  • 1.0% IP-001 for Injection
  • Bordeaux, France
  • +9 more
Jan 26, 2023

Non Small Cell Lung Cancer, Lung Cancer Stage III Trial in Dallas (Thoracic RT and Durvalumab, Consolidative Durvalumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer Stage III
  • Thoracic RT and Durvalumab
  • Consolidative Durvalumab
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 27, 2021

Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Durvalumab
  • +2 more
  • Phoenix, Arizona
  • +41 more
Jul 16, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022